2021 annual financial data
Corcept Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 45.87%.
Operating income was 124,477,000 USD and net income was 112,512,000 USD.
Operating cash flow was 167,892,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 365,978,000 USD
- Operating income
- 124,477,000 USD
- Net income
- 112,512,000 USD
- Operating cash flow
- 167,892,000 USD